The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Vaniqa 11.5%

30 gram(s) Cream

Almirall, S.A.EU/1/01/173/002

Main Information

Trade NameVaniqa 11.5%
Active SubstancesEflornithine
Strength30 gram(s)
Dosage FormCream
Licence HolderAlmirall, S.A.
Licence NumberEU/1/01/173/002

Group Information

ATC CodeP01CX Other agents against leishmaniasis and trypanosomiasis
P01CX03 eflornithine

Status

Authorised/WithdrawnAuthorised
Licence Issued28/03/2001
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back